Wockhardt Limited Wockhardt Limited

Wockhardt Limited

WOCKPHARMA

Kedudukan dalam Saham #4519
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Harga Saham
$21.04
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$3.42B
Perubahan (1 hari)
-2.39%
Perubahan (1 tahun)
34.90%
Negara
IN
Perdagangan Wockhardt Limited (WOCKPHARMA)

Kategori

Healthcare
Sejarah pecahan saham untuk Wockhardt Limited (WOCKPHARMA)
Saham Wockhardt Limited (simbol: WOCKPHARMA) telah mengalami sejumlah 2 pecahan saham.
Pecahan saham terkini berlaku pada Mar 08, 2022.
Satu saham WOCKPHARMA yang dibeli sebelum Apr 28, 2004 kini bersamaan dengan 3.255 saham WOCKPHARMA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2022-03-08 217:200 x1.085 x3.255
2004-04-28 3:1 x3 x3
Pecahan saham untuk syarikat pesaing atau serupa